Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012

Author:

Tahara Makoto1ORCID,Muro Kei2,Hasegawa Yasuhisa2,Chung Hyun Cheol3,Lin Chia-Chi4,Keam Bhumsuk5,Takahashi Kenichi6,Cheng Jonathan D.7,Bang Yung-Jue5

Affiliation:

1. National Cancer Center Hospital East; Kashiwa Japan

2. Aichi Cancer Center Hospital; Nagoya Japan

3. Yonsei Cancer Center; Seoul Korea

4. National Taiwan University Hospital; Taipei Taiwan

5. Seoul National University College of Medicine; Seoul Korea

6. MSD K.K; Tokyo Japan

7. Merck & Co., Inc.; Kenilworth NJ USA

Funder

Merck

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Reference24 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer.,2015

2. Global epidemiology of head and neck cancers: a continuing challenge;Gupta;Oncology,2016

3. Epidemiology and inequality in the incidence and mortality of nasopharynx cancer in Asia;Mahdavifar;Osong Public Health Res Perspect,2016

4. Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver;Pelucchi;Alcohol Res Health,2006

5. State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013;Denaro;Oncology,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3